Page 162 - Mercy MOR All Regions_FinalwVideo

Key Performance Indicators Metric 4,441 4,725 ($100) % Variance 30.0% $11,376,020
St. Charles Hospital
Prior
Variance
Actual
Budget
-21.6%
($297,980)
$1,381,021
$1,679,001
Supply Expense
$1,561,848
$11,515,246
$10,794,490
-6.3%
Net Patient Revenue
($720,756)
Supply Expense % Net Patient Revenue
15.6%
13.7%
3.6%
12.0%
$887
-11.6%
$862
$962
Supply Expense per EIPA
822
16.7%
959

137

956
Total Admissions
-6.0%

Total Patient Days
4,999
(284)
Total EIPAs
143
1,603

1,760
8.9%
1,746
104

77

IP Surgeries

493
-5.1%

468

OP Surgeries
(25)

Total Surgeries
598
(53)

-8.9%
545
Site Performance Summary (27) -26.0% 119 416 535
Supply expense unfavorable to budget by $297K. Admissions & ED visits were up 16.7% & 1.3% respectively while patient days declined
6%. IP Surgery volume increased both to budget & PY while OP missed budget but higher than PY.
Surgery volume increased from 633 TY versus 581 PY.
Service lines with largest increase were GI (69) & OB/GYN (6). Other service lines flat with PY except Gen Surg which was down (17 ).
Supply expense variance primarly driven by Rx ($147K), Med/Surg ($33.4K), Impant Other ($24K) & IV supplies ($26K).
Pharmacy experienced increases in Hormone & Synthetic ($39.8K), Blood coagulant ($26.4K) & Diagnostic ($18.5K) drugs. Med/Surg
expense in support of new Vascular Surgeon, Dr Hacker (Vascular), Implant Other increase due to new Surgeons; Drs Hacker (Vascular) &
Dr Momoh (Ortho) while IV supply expense driven largely by spike in flu cases. Overall flu related supply expense was $37.1K.
St. Charles Hospital Leader's Summary
Key Challenges
Increased spend for new Vascular Surgeon, Dr Hacker - $20K
Med/Surg
Higher RX expense coming from Oncology
Rx
Impact from new Ortho Surgeon (Dr Momoh) & Vascular Surgeon (Dr Hacker) - $22.4K
Implants Ortho volume declined along with average cost per case - $226
Impact of Navio robotic cases
Impact of flu related supplies - $37.1K
Other Expenses
Actions Taken/Planned:
Convert 3 port to 2 port IV set
Met with Pharmacy Director on Rx spend
Met with Surgery to understand impact of Navio robotic cases